Furthermore, the levels of CXCL10, a key chemokine produced by activated bronchial and alveolar epithelial cells in response to infections and involved in the etiology of various pulmonary conditions (such as pulmonary fibrosis), have been found to be increased early in COVID-19 patients. The gene discussed is CXCL10; the disease is COVID-19.